Evidence map›Paper›PMID 35991015›Full record

ArticleFrontiers in public health2022

A graph convolutional network for predicting COVID-19 dynamics in 190 regions/countries.

Sumiko Anno, Tsubasa Hirakawa, Satoru Sugita, Shinya Yasumoto

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sumiko AnnoGraduate School of Global Environmental Studies, Sophia University, Tokyo, Japan.
Tsubasa HirakawaChubu Institute for Advanced Studies, Chubu University, Kasugai, Japan.
Satoru SugitaChubu Institute for Advanced Studies, Chubu University, Kasugai, Japan.
Shinya YasumotoChubu Institute for Advanced Studies, Chubu University, Kasugai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Coronavirus disease (COVID-19) rapidly spread from Wuhan, China to other parts of China and other regions/countries around the world, resulting in a pandemic due to large populations moving through the massive transport hubs connecting all regions of China Methods: This study attempts to utilize a three-layer graph convolutional network (GCN) model to predict future COVID-19 cases in 190 regions and countries using COVID-19 case data, commercial flight route data, and digital maps of public transportation in terms of transnational human mobility. We compared the performance of the proposed GCN model to a multilayer perceptron (MLP) model on a dataset of COVID-19 cases (excluding the graph representation). The prediction performance of the models was evaluated using the mean squared error. Results: Our results demonstrate that the proposed GCN model can achieve better graph utilization and performance compared to the baseline in terms of both prediction accuracy and stability. Discussion: The proposed GCN model is a useful means to predict COVID-19 cases at regional and national levels. Such predictions can be used to facilitate public health solutions in public health responses to the COVID-19 pandemic using deep learning and data pooling. In addition, the proposed GCN model may help public health policymakers in decision making in terms of epidemic prevention and control strategies.

Indexed as

COVID-19PandemicsForecastingHumansNeural Networks, ComputerPublic HealthCOVID-19deep learninggraph convolutional networkpredictingpublic transportation

Identifiers

PMID35991015
PMCPMC9381970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.